|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-3-27
|
|
pubmed:abstractText |
Our aim was to analyze the efficacy and safety of didanosine-lamivudine-efavirenz in a cohort of HIV patients starting antiretroviral therapy between January and September 2003.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1528-4336
|
|
pubmed:author |
pubmed-author:GálvezM CMC,
pubmed-author:Grupo Andaluz para el Estudio de las Enfermedades Infecciosas,
pubmed-author:López-CortésL FLF,
pubmed-author:LópezMM,
pubmed-author:LozanoFF,
pubmed-author:PalaciosRR,
pubmed-author:RíosM JMJ,
pubmed-author:RiveroAA,
pubmed-author:SantosJJ,
pubmed-author:Torres-TortosaMM,
pubmed-author:de la TorreJJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
320-8
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16566083-Administration, Oral,
pubmed-meshheading:16566083-Adult,
pubmed-meshheading:16566083-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:16566083-Benzoxazines,
pubmed-meshheading:16566083-CD4 Lymphocyte Count,
pubmed-meshheading:16566083-Cohort Studies,
pubmed-meshheading:16566083-Didanosine,
pubmed-meshheading:16566083-Drug Administration Schedule,
pubmed-meshheading:16566083-Female,
pubmed-meshheading:16566083-HIV Infections,
pubmed-meshheading:16566083-HIV-1,
pubmed-meshheading:16566083-Humans,
pubmed-meshheading:16566083-Lamivudine,
pubmed-meshheading:16566083-Male,
pubmed-meshheading:16566083-Oxazines,
pubmed-meshheading:16566083-Patient Compliance,
pubmed-meshheading:16566083-Prospective Studies,
pubmed-meshheading:16566083-Quality of Life,
pubmed-meshheading:16566083-RNA, Viral,
pubmed-meshheading:16566083-Reverse Transcriptase Inhibitors,
pubmed-meshheading:16566083-Statistics, Nonparametric
|
|
pubmed:articleTitle |
Simplicity and efficacy of a once-daily antiretroviral regimen with didanosine, lamivudine, and efavirenz in naïve patients: the VESD study.
|
|
pubmed:affiliation |
Infectious Diseases Unit, Hospital Virgen de la Victoria, Málaga, Spain. med000854@saludalia.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|
